Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Merck_&_Co.
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:CEO |
gptkb:Mark_McKenna
|
| gptkbp:focusesOn |
immunology
gastroenterology precision therapeutics |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
gptkb:Mark_McKenna
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
PR300
PR600 |
| gptkbp:parentCompany |
gptkb:Merck_&_Co.
|
| gptkbp:stockSymbol |
gptkb:RXDX
|
| gptkbp:website |
https://www.prometheusbiosciences.com/
|
| gptkbp:bfsParent |
gptkb:Foresite_Capital
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Prometheus Biosciences
|